DNA (Deoxyribonucleic acid) comprises the blueprints of life. Within the structure of DNA, there are codes which are required for the assembly of proteins and non-coding RNA; these molecular machineries are responsible for affecting the biological systems that are creating and maintaining life. By understanding the DNA sequence, researchers have been able to interpret the structure and function of proteins, RNA, and have also gained an understanding of the underlying causes of diseases. Next-Generation Sequencing (NGS) is a powerful platform that enables the sequencing of a large number of DNA molecules simultaneously. It is a high-throughput methodology that enables rapid sequencing of samples consisting of DNA or RNA base pairs. NGS supports a broad range of applications including, chromosome counting, gene expression profiling, molecular analysis, and detection of epigenetic changes. NGS is boosting discovery and enabling the personalized medicine future, also revolutionizing fields, such as, genetic diseases and clinical diagnostics with the capability to sequence multiple individuals at the same time. According to the European Bioinformatics Institute (EBI), next-generation sequencing is the catch-all term used to describe a number of modern sequencing technologies including, the roche 454 sequencing, illumina (solexa) sequencing, SOLiD sequencing, and ion torrent: proton / PGM sequencing. 

The global NGS services market is primarily driven by factors, such as, plunging cost of sequencing, technological advancements in NGS, increasing requirement for skilled professionals for efficient sample preparation and analysis of NGS, exorbitant cost of sequencing infrastructure, and expansion in genome mapping programs. Moreover, rising applications in agrigenomics and oncology research and need for complex sequencing data analysis provides major opportunities for NGS service providers. However, installation of in-house sequencing facilities in hospitals and universities is anticipated to hinder the growth of next-generation sequencing (NGS) services market in the near future.

In terms of service type, the next-generation sequencing (NGS) services market can be segmented into targeted sequencing, exome sequencing, RNA sequencing, de novo sequencing, whole genome sequencing, ChIP-sequencing, methyl sequencing, and other services. Based on technology, the next-generation sequencing (NGS) services market can be classified into ion semiconductor sequencing (IOS), single molecule real time sequencing (SMRT), sequencing by synthesis (SBS), nanopore sequencing, and true single molecule sequencing (tSMS). In terms of application, the next-generation sequencing (NGS) services market can be divided into diagnostics, biomarker discovery, drug discovery, agriculture & animal research, and other applications. In terms of end-user, the next-generation sequencing (NGS) services market can be segmented into academic & research Institutes, hospitals & clinics, pharmaceutical & biotechnology industry, and others.

Based on geography, the next-generation sequencing (NGS) services market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global market due to factors, such as, effective regulatory guidelines regarding approval and use of genetic tests, well-entrenched network of informatics, and strong presence of prominent leaders in the region. Moreover, increasing number of FDA approved genomic tests in the U.S., rising high burden of infectious and chronic diseases, growing R&D expenditure, and rising awareness regarding NGS services are driving the next-generation sequencing (NGS) services market in North America. Asia Pacific is expected to be the fastest growing market for NGS services due to factors, such as, growing population, increasing prevalence of diseases, initiatives taken by government toward public health maintenance, and rise in research and development in diagnostics. 

Key players functioning in the global next-generation sequencing (NGS) services market are BGI, Illumina, Inc., Novogene Corporation, Veritas, QIAGEN, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., Genotypic Technology Pvt Ltd, and SciGenom Labs Pvt. Ltd. For gaining competitive advantage in the market, these players are involved actively in different growth strategies, such as, partnerships, agreements, collaborations, and new product development.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.